Is genetic background important in lung cancer survival? by Linda S Lindström, Per Hall, Mikael Hartman, Fredrik Wiklund, Kamila Czene

Get full text

Reclassifying tumour cell cycle activity in terms of its tissue of origin by Arian Lundberg, Joan Jong Jing Yi, Linda S. Lindström, Nicholas P. Tobin

Get full text

Clinically relevant gene signatures provide independent prognostic information in older breast cancer patients by Miguel Castresana-Aguirre, Annelie Johansson, Alexios Matikas, Theodoros Foukakis, Linda S. Lindström, Nicholas P. Tobin

Get full text

Prognostic and Predictive Significance of Stromal Tumor-Infiltrating Lymphocytes (sTILs) in ER-Positive/HER2−Negative Postmenopausal Breast Cancer Patients by Jenny Pousette, Annelie Johansson, Carolin Jönsson, Tommy Fornander, Linda S. Lindström, Hans Olsson, Gizeh Perez-Tenorio

Get full text

The long-term prognostic and predictive capacity of cyclin D1 gene amplification in 2305 breast tumours by Arian Lundberg, Linda S. Lindström, Jingmei Li, J. Chuck Harrell, Eva Darai-Ramqvist, Emmanouil G. Sifakis, Theodoros Foukakis, Charles M. Perou, Kamila Czene, Jonas Bergh, Nicholas P. Tobin

Get full text

MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit by Sanne Løkkegaard, Daniel Elias, Carla L. Alves, Martin V. Bennetzen, Anne-Vibeke Lænkholm, Martin Bak, Morten F. Gjerstorff, Lene E. Johansen, Henriette Vever, Christina Bjerre, Tove Kirkegaard, Bo Nordenskjöld, Tommy Fornander, Olle Stål, Linda S. Lindström, Laura J. Esserman, Anne E. Lykkesfeldt, Jens S. Andersen, Rikke Leth-Larsen, Henrik J. Ditzel

Get full text